Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7501 USD | 0.00% | -0.03% | +0.96% |
05-13 | Earnings Flash (CARA) CARA THERAPEUTICS Posts Q1 Revenue $2.1M, vs. Street Est of $1.7M | MT |
05-13 | Cara Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+0.96% | 41.01M | |
-2.78% | 90.45B | |
+3.95% | 41.45B | |
-10.51% | 33.57B | |
+60.58% | 25.73B | |
-20.09% | 14.73B | |
-8.92% | 12.82B | |
-11.46% | 11.7B | |
-43.05% | 11.44B | |
+5.17% | 8.79B |
- Stock Market
- Equities
- CARA Stock
- News Cara Therapeutics, Inc.
- BofA Securities Adjusts Price Target on Cara Therapeutics to $4 From $6, Maintains Underperform Rating